Apimeds Pharmaceuticals US, Inc. Business Finance Contracts & Agreements
16 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Loan Agreements (3)
- Note Agreements (10)
- Underwriting Agreements (1)
- Amended Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 12, 2024 (Filed With SEC on September 25, 2024)
- Convertible Note Assignment Agreement (March 2022 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024 (Filed With SEC on September 25, 2024)
- Convertible Note Assignment Agreement (August 2021 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024 (Filed With SEC on September 25, 2024)
- May 2024 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated May 20, 2022 (Filed With SEC on September 25, 2024)
- Loan Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated March 16, 2023 (Filed With SEC on September 25, 2024)
- Loan Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated November 10, 2022 (Filed With SEC on September 25, 2024)
- Loan Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated October 5, 2022 (Filed With SEC on September 25, 2024)
- Intellectual Property Assignment Agreement by and between Apimeds Pharmaceuticals US, Inc. Apimeds Inc. and Christopher Kim, dated October 12, 2021 (Filed With SEC on September 25, 2024)
- Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated December 5, 2023 (Filed With SEC on September 25, 2024)
- June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 3, 2022 (Filed With SEC on September 25, 2024)
- Amendment to the March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023 (Filed With SEC on September 25, 2024)
- March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated March 21, 2022 (Filed With SEC on September 25, 2024)
- Amendment to the August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023 (Filed With SEC on September 25, 2024)
- August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated August 30, 2021 (Filed With SEC on September 25, 2024)
- Assignment Agreement by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated October 12, 2021 (Filed With SEC on September 25, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 25, 2024)
